Inventor
SIPPY KEVIN B
US31 patents
⚠️ This page may combine multiple inventors who share the name “SIPPY KEVIN B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
17 patentsUS6809105B2Oct 26, 2004
Diazabicyclic central nervous system active agents
ABBOTT LAB53 citations95
US7902222B2Mar 8, 2011
Biaryl substituted azabicyclic alkane derivatives
ABBOTT LAB28 citations92
US5792767AAug 11, 1998
Bicyclic substituted hexahydrobenz e! isoindole alpha-1 adrenergic antagonists
ABBOTT LAB37 citations92
US5597823AJan 28, 1997
Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists
ABBOTT LAB31 citations92
US5244888ASep 14, 1993
5-HT selective agents
ABBOTT LAB26 citations92
US5049564ASep 17, 1991
5-HT selective agents
ABBOTT LAB42 citations92
US6833370B1Dec 21, 2004
Heterocycle substituted aminoazacycles useful as central nervous system agents
ABBOTT LAB40 citations91
US5288749AFeb 22, 1994
Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
ABBOTT LAB26 citations91
US7319106B2Jan 15, 2008
Diazabicyclic central nervous system active agents
ABBOTT LAB5 citations73
US5521181AMay 28, 1996
Bicyclic substituted hexahydrobenz[e]isoindole α-1 adrenergic antagonists
ABBOTT LAB15 citations72
US7897766B2Mar 1, 2011
Amino-aza-adamantane derivatives and methods of use
ABBOTT LAB3 citations62
US7365193B2Apr 29, 2008
Amino-substituted tricyclic derivatives and methods of use
ABBOTT LAB3 citations62
US7332504B2Feb 19, 2008
Heterocyclic substituted aminoazacycles useful as central nervous system agents
ABBOTT LAB2 citations61
US8383658B2Feb 26, 2013
Isoxazole based neuronal nicotinic receptor ligands and methods of use
ABBOTT LAB0 citations52
US7598236B2Oct 6, 2009
Diazabicyclic central nervous system active agents
ABBOTT LAB0 citations52
US7951791B2May 31, 2011
Amino-substituted tricyclic derivatives and methods of use
ABBOTT LAB0 citations51
US7265115B2Sep 4, 2007
Diazabicyclic CNS active agents
ABBOTT LAB1 citations49
SCHRIMPF MICHAEL R
7 patentsUS8314119B2Nov 20, 2012
Azaadamantane derivatives and methods of use
SCHRIMPF MICHAEL R22 citations92
US8846661B2Sep 30, 2014
Diazahomoadamantane derivatives and methods of use thereof
SCHRIMPF MICHAEL R17 citations83
US8586746B2Nov 19, 2013
Amino-aza-adamantane derivatives and methods of use
SCHRIMPF MICHAEL R3 citations62
US8163916B2Apr 24, 2012
Azaadamantane ester and carbamate derivatives and methods of use thereof
SCHRIMPF MICHAEL R5 citations62
US8119635B2Feb 21, 2012
Diazabicyclic central nervous system active agents
SCHRIMPF MICHAEL R2 citations62
US9063126B2Jun 23, 2015
Indole and indoline derivatives and methods of use thereof
SCHRIMPF MICHAEL R2 citations61
US9625475B2Apr 18, 2017
Indole and indoline derivatives and methods of use thereof
SCHRIMPF MICHAEL R1 citations51